KR20120106016A - Natural fermentation hair restorer and the manufacturing method thereof - Google Patents
Natural fermentation hair restorer and the manufacturing method thereof Download PDFInfo
- Publication number
- KR20120106016A KR20120106016A KR1020110023819A KR20110023819A KR20120106016A KR 20120106016 A KR20120106016 A KR 20120106016A KR 1020110023819 A KR1020110023819 A KR 1020110023819A KR 20110023819 A KR20110023819 A KR 20110023819A KR 20120106016 A KR20120106016 A KR 20120106016A
- Authority
- KR
- South Korea
- Prior art keywords
- fermentation
- extract
- fermented
- months
- hair
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 123
- 230000004151 fermentation Effects 0.000 title claims abstract description 123
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 36
- 210000004209 hair Anatomy 0.000 title claims abstract description 24
- 239000000284 extract Substances 0.000 claims abstract description 128
- 239000000203 mixture Substances 0.000 claims abstract description 35
- 230000001954 sterilising effect Effects 0.000 claims abstract description 30
- 240000002234 Allium sativum Species 0.000 claims abstract description 25
- 235000004611 garlic Nutrition 0.000 claims abstract description 25
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 21
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 20
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 20
- 244000068988 Glycine max Species 0.000 claims abstract description 18
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 18
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 15
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000011593 sulfur Substances 0.000 claims abstract description 12
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 9
- 239000005871 repellent Substances 0.000 claims abstract description 7
- 230000002940 repellent Effects 0.000 claims abstract description 5
- 230000003659 hair regrowth Effects 0.000 claims description 29
- 238000000034 method Methods 0.000 claims description 29
- 210000004761 scalp Anatomy 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 229920000615 alginic acid Polymers 0.000 claims description 19
- 235000010443 alginic acid Nutrition 0.000 claims description 19
- 239000002994 raw material Substances 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 239000000783 alginic acid Substances 0.000 claims description 16
- 229960001126 alginic acid Drugs 0.000 claims description 16
- 150000004781 alginic acids Chemical class 0.000 claims description 16
- 239000003795 chemical substances by application Substances 0.000 claims description 13
- 244000005700 microbiome Species 0.000 claims description 13
- 239000007787 solid Substances 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- 241000235070 Saccharomyces Species 0.000 claims description 11
- 230000009471 action Effects 0.000 claims description 11
- 239000012535 impurity Substances 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 9
- 238000000746 purification Methods 0.000 claims description 9
- 238000005406 washing Methods 0.000 claims description 9
- 241000208340 Araliaceae Species 0.000 claims description 8
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 8
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 8
- 235000008434 ginseng Nutrition 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 8
- 241001107116 Castanospermum australe Species 0.000 claims description 7
- 235000021279 black bean Nutrition 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000012528 membrane Substances 0.000 claims description 7
- 239000011148 porous material Substances 0.000 claims description 7
- 238000001556 precipitation Methods 0.000 claims description 7
- 240000007817 Olea europaea Species 0.000 claims description 6
- 239000012676 herbal extract Substances 0.000 claims description 6
- 239000004909 Moisturizer Substances 0.000 claims description 5
- 229940069521 aloe extract Drugs 0.000 claims description 5
- 230000019522 cellular metabolic process Effects 0.000 claims description 5
- 239000003995 emulsifying agent Substances 0.000 claims description 5
- 230000001333 moisturizer Effects 0.000 claims description 5
- 229940088594 vitamin Drugs 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 3
- 229940072056 alginate Drugs 0.000 claims description 3
- 230000005484 gravity Effects 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 2
- 210000000442 hair follicle cell Anatomy 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- 229940069765 bean extract Drugs 0.000 claims 1
- 235000020710 ginseng extract Nutrition 0.000 claims 1
- 238000011081 inoculation Methods 0.000 claims 1
- 235000002789 Panax ginseng Nutrition 0.000 abstract description 11
- 235000001508 sulfur Nutrition 0.000 abstract description 4
- 244000171263 Ribes grossularia Species 0.000 abstract description 2
- 235000002357 Ribes grossularia Nutrition 0.000 abstract description 2
- 201000004384 Alopecia Diseases 0.000 description 20
- 230000000694 effects Effects 0.000 description 20
- 230000003779 hair growth Effects 0.000 description 17
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 14
- 230000017531 blood circulation Effects 0.000 description 12
- 230000008569 process Effects 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 206010068168 androgenetic alopecia Diseases 0.000 description 10
- 201000002996 androgenic alopecia Diseases 0.000 description 10
- 230000003078 antioxidant effect Effects 0.000 description 9
- 230000003676 hair loss Effects 0.000 description 9
- 208000024963 hair loss Diseases 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- -1 Fucoxanthine Chemical compound 0.000 description 8
- 235000012000 cholesterol Nutrition 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 241000512259 Ascophyllum nodosum Species 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 6
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 229960003632 minoxidil Drugs 0.000 description 5
- 230000001766 physiological effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 229920000855 Fucoidan Polymers 0.000 description 4
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 239000003146 anticoagulant agent Substances 0.000 description 4
- 229940127219 anticoagulant drug Drugs 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 3
- OSELKOCHBMDKEJ-UHFFFAOYSA-N (10R)-3c-Hydroxy-10r.13c-dimethyl-17c-((R)-1-methyl-4-isopropyl-hexen-(4c)-yl)-(8cH.9tH.14tH)-Delta5-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(=CC)C(C)C)C1(C)CC2 OSELKOCHBMDKEJ-UHFFFAOYSA-N 0.000 description 3
- CQSRUKJFZKVYCY-UHFFFAOYSA-N 5alpha-isofucostan-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(=CC)C(C)C)C1(C)CC2 CQSRUKJFZKVYCY-UHFFFAOYSA-N 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- GBBBJSKVBYJMBG-QTWVXCTBSA-N Fucosterol Natural products CC=C(CC[C@@H](C)[C@@H]1CC[C@@H]2[C@H]3C=C[C@@H]4C[C@H](O)CC[C@@]4(C)[C@@H]3CC[C@@]12C)C(C)C GBBBJSKVBYJMBG-QTWVXCTBSA-N 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- OSELKOCHBMDKEJ-VRUYXKNBSA-N Isofucosterol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@@H]2[C@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C(C)C OSELKOCHBMDKEJ-VRUYXKNBSA-N 0.000 description 3
- 241000199919 Phaeophyceae Species 0.000 description 3
- 229960003473 androstanolone Drugs 0.000 description 3
- 230000001754 anti-pyretic effect Effects 0.000 description 3
- 239000002221 antipyretic Substances 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- OSELKOCHBMDKEJ-JUGJNGJRSA-N fucosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC\C(=C/C)C(C)C)[C@@]1(C)CC2 OSELKOCHBMDKEJ-JUGJNGJRSA-N 0.000 description 3
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- MMCQRJPAMIHLQX-ZOWXZIJZSA-N Sophoramine Chemical compound C1CC[C@H]2CN3C(=O)C=CC=C3[C@@H]3[C@H]2N1CCC3 MMCQRJPAMIHLQX-ZOWXZIJZSA-N 0.000 description 2
- VQYBAEAOOJBSTR-AYRXBEOTSA-N Sophoranol Natural products O=C1N2[C@H]([C@@H]3[C@@H]4[C@](O)(C2)CCCN4CCC3)CCC1 VQYBAEAOOJBSTR-AYRXBEOTSA-N 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- HLXRWTJXGMHOFN-XJSNKYLASA-N Verbenalin Chemical compound O([C@@H]1OC=C([C@H]2C(=O)C[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HLXRWTJXGMHOFN-XJSNKYLASA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000007380 fibre production Methods 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000003658 preventing hair loss Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 239000011677 pyridoxine Substances 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- ADJWEWOIQOTUSH-SWBPCFCJSA-N (+)-Isomatrine Natural products OC[C@@]1(C)[C@@H]2[C@H](O)CC(=C)[C@@H](CCc3cocc3)[C@@]2(C)CCC1 ADJWEWOIQOTUSH-SWBPCFCJSA-N 0.000 description 1
- FQEQMASDZFXSJI-RWMBFGLXSA-N (-)-Anagyrine Natural products C([C@@H]12)CCCN1C[C@H]1C3=CC=CC(=O)N3C[C@@H]2C1 FQEQMASDZFXSJI-RWMBFGLXSA-N 0.000 description 1
- CULUKMPMGVXCEI-NXEZZACHSA-N (-)-N-Methylcytisine Natural products C12=CC=CC(=O)N2C[C@H]2CN(C)C[C@H]1C2 CULUKMPMGVXCEI-NXEZZACHSA-N 0.000 description 1
- NYCXYIWXBJWWIL-PZYDOOQISA-N (2s,3r,4s,5s,6r)-2-[[(1as,1bs,2s,5ar,6s,6as)-6-hydroxy-1a-(hydroxymethyl)-2,4,5,5a,6,6a-hexahydro-1bh-oxireno[5,6]cyclopenta[1,3-c]pyran-2-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2[C@@]3(CO)O[C@H]3[C@@H](O)[C@@H]2CCO1 NYCXYIWXBJWWIL-PZYDOOQISA-N 0.000 description 1
- VELYAQRXBJLJAK-XKKWFBPMSA-N (2s,3r,4s,5s,6r)-2-[[(1s,4ar,5r,7s,7as)-5,7-dihydroxy-7-methyl-4a,5,6,7a-tetrahydro-1h-cyclopenta[c]pyran-1-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O([C@@H]1OC=C[C@H]2[C@H](O)C[C@@]([C@@H]12)(O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VELYAQRXBJLJAK-XKKWFBPMSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- IXELFRRANAOWSF-FNORWQNLSA-N (E)-Ajoene Chemical compound C=CCSS\C=C\CS(=O)CC=C IXELFRRANAOWSF-FNORWQNLSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 1
- XUHLIQGRKRUKPH-GCXOYZPQSA-N Alliin Natural products N[C@H](C[S@@](=O)CC=C)C(O)=O XUHLIQGRKRUKPH-GCXOYZPQSA-N 0.000 description 1
- WNCAVNGLACHSRZ-KAMYIIQDSA-N Allithiamine Chemical compound C=CCSSC(/CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N WNCAVNGLACHSRZ-KAMYIIQDSA-N 0.000 description 1
- WNCAVNGLACHSRZ-UHFFFAOYSA-N Allithiamine Natural products C=CCSSC(CCO)=C(C)N(C=O)CC1=CN=C(C)N=C1N WNCAVNGLACHSRZ-UHFFFAOYSA-N 0.000 description 1
- FQEQMASDZFXSJI-UHFFFAOYSA-N Anagyrin Natural products C12CCCCN2CC2C3=CC=CC(=O)N3CC1C2 FQEQMASDZFXSJI-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- ZSBXGIUJOOQZMP-QVHKTLOISA-N Isomatrine Chemical compound C1CC[C@@H]2CN3C(=O)CCC[C@@H]3[C@H]3[C@@H]2N1CCC3 ZSBXGIUJOOQZMP-QVHKTLOISA-N 0.000 description 1
- MMCQRJPAMIHLQX-UHFFFAOYSA-N Isosophoromine Natural products C1CCC2CN3C(=O)C=CC=C3C3C2N1CCC3 MMCQRJPAMIHLQX-UHFFFAOYSA-N 0.000 description 1
- AMBQHHVBBHTQBF-UHFFFAOYSA-N Loganin Natural products C12C(C)C(O)CC2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O AMBQHHVBBHTQBF-UHFFFAOYSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 102100030417 Matrilysin Human genes 0.000 description 1
- 108090000855 Matrilysin Proteins 0.000 description 1
- NLSTZAFFNDSJGQ-UHFFFAOYSA-N Matrin Natural products O=C1CCCN2CC3CCNC4CCCC(C34)C12 NLSTZAFFNDSJGQ-UHFFFAOYSA-N 0.000 description 1
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- CULUKMPMGVXCEI-UHFFFAOYSA-N N-methylcystisine Natural products C12=CC=CC(=O)N2CC2CN(C)CC1C2 CULUKMPMGVXCEI-UHFFFAOYSA-N 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- XACHQDDXHDTRLX-XLVVAOPESA-N Physalien Chemical compound CC1(C)C[C@H](OC(=O)CCCCCCCCCCCCCCC)CC(C)=C1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](OC(=O)CCCCCCCCCCCCCCC)CC1(C)C XACHQDDXHDTRLX-XLVVAOPESA-N 0.000 description 1
- XACHQDDXHDTRLX-GMPBGBGESA-N Physalien Natural products O=C(O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=2C(C)(C)C[C@H](OC(=O)CCCCCCCCCCCCCCC)CC=2C)\C)/C)\C)/C)=C(C)C1)CCCCCCCCCCCCCCC XACHQDDXHDTRLX-GMPBGBGESA-N 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 238000012356 Product development Methods 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 229930195376 Rehmannioside Natural products 0.000 description 1
- XUHLIQGRKRUKPH-UHFFFAOYSA-N S-allyl-L-cysteine sulfoxide Natural products OC(=O)C(N)CS(=O)CC=C XUHLIQGRKRUKPH-UHFFFAOYSA-N 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- VQYBAEAOOJBSTR-QHSBEEBCSA-N Sophoranol Chemical compound C([C@@H]12)CCC(=O)N1C[C@@]1(O)[C@H]3[C@@H]2CCCN3CCC1 VQYBAEAOOJBSTR-QHSBEEBCSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- DWCSNWXARWMZTG-UHFFFAOYSA-N Trigonegenin A Natural products CC1C(C2(CCC3C4(C)CCC(O)C=C4CCC3C2C2)C)C2OC11CCC(C)CO1 DWCSNWXARWMZTG-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- HLXRWTJXGMHOFN-UHFFFAOYSA-N Verbenalin Natural products C12C(C)CC(=O)C2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O HLXRWTJXGMHOFN-UHFFFAOYSA-N 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- XACHQDDXHDTRLX-UHFFFAOYSA-N Zeaxanthin-dipalmitat Natural products CC1(C)CC(OC(=O)CCCCCCCCCCCCCCC)CC(C)=C1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CC(OC(=O)CCCCCCCCCCCCCCC)CC1(C)C XACHQDDXHDTRLX-UHFFFAOYSA-N 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 238000003916 acid precipitation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- IXELFRRANAOWSF-CYBMUJFWSA-N ajoene Natural products C=CCSSC=CC[S@](=O)CC=C IXELFRRANAOWSF-CYBMUJFWSA-N 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 1
- 235000010081 allicin Nutrition 0.000 description 1
- XUHLIQGRKRUKPH-DYEAUMGKSA-N alliin Chemical compound OC(=O)[C@@H](N)C[S@@](=O)CC=C XUHLIQGRKRUKPH-DYEAUMGKSA-N 0.000 description 1
- 235000015295 alliin Nutrition 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- FQEQMASDZFXSJI-YNEHKIRRSA-N anagyrine Chemical compound C([C@@H]12)CCCN1C[C@H]1C3=CC=CC(=O)N3C[C@H]2C1 FQEQMASDZFXSJI-YNEHKIRRSA-N 0.000 description 1
- ICFWMXKHGNCJTK-UHFFFAOYSA-N anagyrine Natural products O=C1C=CC=C2C3CC(CC4CCCCN4C3)N12 ICFWMXKHGNCJTK-UHFFFAOYSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003656 anti-hair-loss Effects 0.000 description 1
- 239000003529 anticholesteremic agent Substances 0.000 description 1
- 229940127226 anticholesterol agent Drugs 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- RJWJHRPNHPHBRN-FKVJWERZSA-N aucubin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2C(CO)=C[C@@H](O)[C@@H]2C=CO1 RJWJHRPNHPHBRN-FKVJWERZSA-N 0.000 description 1
- UTDFQMAXCUGNJR-UHFFFAOYSA-N aucubin Natural products OCC1OC(Oc2ccoc2C3C(O)CCC3O)C(O)C(O)C1O UTDFQMAXCUGNJR-UHFFFAOYSA-N 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- 102000007478 beta-N-Acetylhexosaminidases Human genes 0.000 description 1
- 108010085377 beta-N-Acetylhexosaminidases Proteins 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- ZEASOXUPPLSUSE-UHFFFAOYSA-N butanedioic acid;sulfane Chemical compound S.OC(=O)CCC(O)=O ZEASOXUPPLSUSE-UHFFFAOYSA-N 0.000 description 1
- 230000008822 capillary blood flow Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- LHDWRKICQLTVDL-PZYDOOQISA-N catalpol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2[C@@]3(CO)O[C@H]3[C@@H](O)[C@@H]2C=CO1 LHDWRKICQLTVDL-PZYDOOQISA-N 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- IXELFRRANAOWSF-UHFFFAOYSA-N cis-ajoene Natural products C=CCSSC=CCS(=O)CC=C IXELFRRANAOWSF-UHFFFAOYSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- NYCXYIWXBJWWIL-UHFFFAOYSA-N dihydrocatalpol Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(O)C2CCO1 NYCXYIWXBJWWIL-UHFFFAOYSA-N 0.000 description 1
- WQLVFSAGQJTQCK-VKROHFNGSA-N diosgenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 WQLVFSAGQJTQCK-VKROHFNGSA-N 0.000 description 1
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 210000004919 hair shaft Anatomy 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- AMBQHHVBBHTQBF-UOUCRYGSSA-N loganin Chemical compound O([C@@H]1OC=C([C@H]2C[C@H](O)[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O AMBQHHVBBHTQBF-UOUCRYGSSA-N 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 229930014456 matrine Natural products 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 230000009247 menarche Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- LHDWRKICQLTVDL-UHFFFAOYSA-N methyl iridoid glycoside Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(O)C2C=CO1 LHDWRKICQLTVDL-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- VELYAQRXBJLJAK-UHFFFAOYSA-N myoporoside Natural products C12C(C)(O)CC(O)C2C=COC1OC1OC(CO)C(O)C(O)C1O VELYAQRXBJLJAK-UHFFFAOYSA-N 0.000 description 1
- CULUKMPMGVXCEI-VHSXEESVSA-N n-methylcytisine Chemical compound C12=CC=CC(=O)N2C[C@@H]2CN(C)C[C@H]1C2 CULUKMPMGVXCEI-VHSXEESVSA-N 0.000 description 1
- 230000014508 negative regulation of coagulation Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 125000004394 rehmannioside group Chemical group 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000008729 scordinin Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- ZSBXGIUJOOQZMP-BHPKHCPMSA-N sophoridine Chemical compound C1CC[C@@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-BHPKHCPMSA-N 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940032362 superoxide dismutase Drugs 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000003813 thin hair Effects 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/94—Saccharomyces
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 천연 발효 발모제 톳, 숙지황, 고삼, 마늘, 구기자, 검은콩 등의 조성물의 제조 방법에 관한 것으로, 발모제의 제조 방법에 있어서, 분쇄한 톳 분말을 살균 처리한 후, 35℃에서 6개월 이상 발효하여 추출하는 톳 발효 추출물 제조 단계; 숙지황, 고삼, 마늘, 구기자 및 검은콩을 살균 처리한 후, 35℃에서 3개월간 발효하여 추출하는 1차 생약 발효 추출물 제조 단계; 및 상기 1차 발효된 숙지황 발효 추출물, 고삼 발효 추출물, 마늘 발효 추출물, 구기자 발효 추출물 및 검은콩 발효 추출물을 혼합하여 30℃에서 3개월 이상 2차 발효시키는 2차 생약 발효 추출물 제조 단계;를 포함함을 특징으로 한다.The present invention relates to a method for producing a composition such as natural fermented hair repellent 숙, Sukji sulfur, red ginseng, garlic, wolfberry, black soybean, etc., in the method for producing a hair repellent, after sterilizing the pulverized 톳 powder, 6 months at 35 ℃ 톳 fermentation extract manufacturing step of extracting by fermentation; After the sterilization treatment of Sukjihwang, red ginseng, garlic, wolfberry and black soybeans, fermented extract of the first herbal fermented extract prepared by fermentation for 3 months at 35 ℃; And a second herbal fermentation extract manufacturing step of fermenting the first fermented Sookji sulfur fermentation extract, gooseberry fermentation extract, garlic fermentation extract, goji berry fermentation extract and black soybean fermentation extract to ferment for 2 months at 30 ° C. for 2 months or more. It is characterized by.
Description
본 발명은 천연 발모제 조성물 및 그 제조 방법에 관한 것으로, 보다 상세하게는 톳과 각종 생약 재료를 발효시킨 추출물을 사용함으로써 다양한 탈모 원인에 대한 개선 효과를 가지는 천연 발효 발모제 조성물 및 그 제조 방법에 관한 것이다.The present invention relates to a natural hair regrowth composition and a method for producing the same, and more particularly, to a natural fermentation hair regrowth composition and a method for producing the same having an effect of improving the hair loss by using a fermented extract of fermented herbs and various herbal ingredients. .
탈모의 주된 원인으로는 남성호르몬의 노폐물인 디하이드로 테스토스테론(dihydrotestosterone, DHT) 작용, 과민성 두피, 지용성 두피, 모근혈류량 감소, 스트레스 등이 있다. 따라서, 이와 같은 원인을 제거함으로써 발모를 촉진할 수 있다.The main causes of hair loss include the action of dihydrotestosterone (DHT), a waste product of male hormones, irritable scalp, fat-soluble scalp, decreased hair root blood flow, and stress. Therefore, hair removal can be promoted by eliminating such a cause.
한편, 이러한 탈모증의 치료나 예방에 있어서 주로 사용하는 발모제로는 미녹시딜 함유제제가 있다. 상기한 미녹시딜은 혈압강하의 목적으로 개발된 고혈압 치료제이었는데, 사용상의 부작용으로 발모현상이 나타나면서 현재는 발모제로 더 널리 사용되고 있다.On the other hand, a minoxidil-containing agent is a hair regrowth agent mainly used in the treatment and prevention of such alopecia. Minoxidil was a high blood pressure treatment drug developed for the purpose of lowering blood pressure, and as a side effect of use, hair growth phenomenon is now widely used as a hair growth agent.
상기한 미녹시딜의 발모작용기전에 대해서는 정확하게 밝혀지지 않았지만, 대체로 혈관확장효과를 통한 혈류량 증가로 모근에 영양을 공급하여 모발성장을 촉진하는 것으로 알려져 있다. 그런데 상기한 미녹시딜은 잔털이 굵어지는 것으로서, 사용을 중단하면 효과도 중지되어 원래의 상태로 되돌아간다는 문제가 있다.Although the exact mechanism of the hair growth action of minoxidil is not known, it is generally known to promote hair growth by nourishing hair roots by increasing blood flow through vasodilation effect. However, the minoxidil has a problem that the fine hair is thickened, and when the use thereof is stopped, the effect is also stopped and returned to its original state.
미녹시딜 이외에도 발모제로서 은행추출물 및 홍삼추출물을 함유하는 조성물(대한민국 공개특허공보 제2000-38214호), 난초과 식물의 추출물을 함유하는 조성물(대한민국 특허 제157667호), 녹두분과 대두분 등 곡분과 홍합분 등을 함유하는 조성물(대한민국 특허 제260673호), 한방에서 사용하는 상백피와 측백엽 및 생강 등의 즙액을 함유하는 조성물(대한민국 특허 제201589호) 등이 알려져 있지만, 아직까지 확실한 탈모방지나 발모가 이루어지는 제품의 개발이 활발하게 이루어지지 않고 있다.In addition to minoxidil, a composition containing ginkgo extract and red ginseng extract as a hair regrowth agent (Korean Patent Publication No. 2000-38214), a composition containing an extract of orchid family (Korean Patent No. 157667), flour and mussel powder such as mung bean powder and soybean powder Etc. (Korean Patent No. 260673), and compositions containing juices such as baekbaekpi and baekyeop and ginger used in herbal medicine (Korean Patent No. 201589), etc. are known, but there is still a certain prevention of hair loss and hair growth Product development is not active.
또한, 이러한 기존 발모제들은 상술한 다양한 탈모의 원인 중에서 한 종류의 원인에 대해서만 개선 기능을 갖기 때문에 실질적으로 발모에 큰 효과를 나타내고 있지 못한 실정이다.
In addition, these conventional hair regrowth agents do not show a significant effect on hair growth substantially because they have an improvement function for only one type of causes of the above-mentioned various hair loss.
본 발명의 목적은 톳과 각종 생약 재료를 발효시킨 추출물을 사용함으로써, 남성호르몬의 노폐물인 DHT 작용을 억제하고, 두피의 과민성 반응을 억제하며, 두피의 지질 과잉 방출을 억제함으로써 지용성 두피를 개선하여 발모를 촉진하는 천연 발효 발모제 조성물 및 그 제조 방법을 제공함에 있다.The purpose of the present invention is to improve the fat-soluble scalp by inhibiting DHT action, a waste product of male hormones, inhibiting hypersensitivity reactions of the scalp, and inhibiting the excessive release of lipids of the scalp by using extracts fermented with bovine and various herbal ingredients. It is to provide a natural fermentation hair regrowth composition for promoting hair growth and a method for producing the same.
또한, 본 발명의 목적은 톳과 각종 생약 재료를 발효시킨 추출물을 사용함으로써, 두피 조직의 이완 및 모세혈관의 혈류 양을 개선하여 모근 활성을 촉진함으로써 발모를 촉진하는 천연 발효 발모제 조성물 및 그 제조 방법을 제공함에 있다.
In addition, an object of the present invention is a natural fermented hair regrowth composition and method for producing the same, which promote hair growth by promoting the hair root activity by improving the amount of blood flow in the capillaries and the relaxation of the scalp tissue by using the extract fermented with 톳 and various herbal ingredients In providing.
상기한 목적을 달성하기 위하여, 본 발명에 따른 천연 발효 발모제 조성물은, 발모제의 조성물에 있어서, 분쇄한 톳 분말을 살균 처리한 후, 35℃에서 6개월 이상 발효하여 추출한 톳 발효 추출물; 숙지황을 살균 처리한 후, 35℃에서 3개월간 발효하여 추출한 숙지황 발효 추출물; 고삼을 살균 처리한 후, 35℃에서 3개월간 발효하여 추출한 고삼 발효 추출물; 마늘을 살균 처리한 후, 35℃에서 3개월간 발효하여 추출한 마늘 발효 추출물; 구기자를 살균 처리한 후, 35℃에서 3개월간 발효하여 추출한 구기자 발효 추출물; 및 검은콩을 살균 처리한 후, 35℃에서 3개월간 발효하여 추출한 검은콩 발효 추출물;을 포함하며, 상기 숙지황 발효 추출물, 고삼 발효 추출물, 마늘 발효 추출물, 구기자 발효 추출물 및 검은콩 발효 추출물은 혼합하여 30℃에서 3개월 이상 2차 발효하는 것을 특징으로 한다.In order to achieve the above object, the natural fermentation hair regrowth composition according to the present invention, in the composition of the hair regrowth, after the sterilization treatment of pulverized powder 톳, 추출물 fermented extract extracted by fermentation for at least 6 months at 35 ℃; Sukji sulfur fermented extract extracted by fermentation for three months after the sterilization of succinct; After sterilizing the ginseng, fermented extract extracted by fermentation for 3 months at 35 ℃; After the sterilization of garlic, garlic fermented extract extracted by fermentation for 3 months at 35 ℃; After sterilization of the wolfberry, fermented extract extracting fermented for 3 months at 35 ℃; And black soybean fermented extract extracted by fermentation at 35 ° C. for 3 months after sterilizing the black soybean; wherein, the ripening sulfur fermented extract, red ginseng fermented extract, garlic fermented extract, wolfberry fermented extract and black soybean fermented extract are mixed It is characterized in that the secondary fermentation for at least 3 months at 30 ℃.
이때, 상기 톳 발효 추출물은, -20℃ 이하에서 동결 침전시켜 알긴산을 분리하는 것을 특징으로 한다.At this time, the fermented extract is characterized in that the alginic acid is separated by freeze precipitation at -20 ℃ or less.
한편, 상기 각 발효 추출물을 발효시키는 방법은, 물과 함께 각 살균 처리한 원료를 발효조에 투입하고, 5 내지 10중량%로 가당한 후, Saccharomyces.spp 균주를 접종하여 발효시키는 것을 특징으로 한다.On the other hand, the method of fermenting each fermentation extract is characterized in that the fermentation tank is added to each fermented raw material with water, added to 5 to 10% by weight, and then fermented by inoculating Saccharomyces.spp strain.
또한, 상기 조성물은 천연 유화제인 올리브 리퀴드, 모근 세포대사 촉진물로 비타민, 두피 보습제로 알로에 추출물을 더 포함함을 특징으로 한다.In addition, the composition is characterized in that it further comprises aloe extract as a natural emulsifier olive liquid, vitamins as hair root cell metabolism promoter, scalp moisturizer.
상기한 목적을 달성하기 위하여, 본 발명에 따른 천연 발효 발모제 조성물의 제조 방법은, 발모제의 제조 방법에 있어서, 분쇄한 톳 분말을 살균 처리한 후, 35℃에서 6개월 이상 발효하여 추출하는 톳 발효 추출물 제조 단계; 숙지황, 고삼, 마늘, 구기자 및 검은콩을 살균 처리한 후, 35℃에서 3개월간 발효하여 추출하는 1차 생약 발효 추출물 제조 단계; 및 상기 1차 발효된 숙지황 발효 추출물, 고삼 발효 추출물, 마늘 발효 추출물, 구기자 발효 추출물 및 검은콩 발효 추출물을 혼합하여 30℃에서 3개월 이상 2차 발효시키는 2차 생약 발효 추출물 제조 단계;를 포함함을 특징으로 한다.In order to achieve the above object, the production method of the natural fermentation hair regrowth composition according to the present invention, in the production method of the hair regrowth, after the sterilized treatment of the ground powder 톳 fermentation, which is extracted by fermentation for 6 months or more at 35 ℃ Extract preparation step; After the sterilization treatment of Sukjihwang, red ginseng, garlic, wolfberry and black soybeans, fermented extract of the first herbal fermented extract prepared by fermentation for 3 months at 35 ℃; And a second herbal fermentation extract manufacturing step of fermenting the first fermented Sookji sulfur fermentation extract, gooseberry fermentation extract, garlic fermentation extract, goji berry fermentation extract and black soybean fermentation extract to ferment for 2 months at 30 ° C. for 2 months or more. It is characterized by.
이때, 상기 톳 발효 추출물 제조 단계는, 상기 발효된 톳 추출물을 -20℃ 이하에서 동결 침전시켜 알긴산을 분리하는 단계;를 더 포함함을 특징으로 한다.At this time, the 톳 fermentation extract manufacturing step, the step of freezing precipitation the fermented 톳 extract at -20 ℃ below to separate the alginic acid; characterized in that it further comprises.
한편, 상기 1차 생약 발효 추출물 제조 단계는, 상기 각 원료를 세정하여 불순물을 제거하는 단계; 상기 세정된 원료를 살균한 후 상온에서 냉각하는 단계; 및 상기 살균 처리된 원료를 물과 함께 발효조에 투입하고, 5 내지 10중량%로 가당한 후, Saccharomyces.spp 균주를 접종하여 발효시키는 단계;를 포함함을 특징으로 한다.On the other hand, the primary herbal fermentation extract manufacturing step, the step of washing each raw material to remove impurities; Sterilizing the washed raw materials and then cooling them at room temperature; And injecting the sterilized raw materials into the fermenter together with water, and adding 5 to 10% by weight, inoculating the Saccharomyces.spp strain and fermenting the same.
또한, 상기 2차 생약 발효 추출물 제조 단계는, 상기 각 1차 발효 추출물을 발효조에 투입하여 혼합하는 단계; 상기 2차 발효된 발효 추출물로부터 미생물을 제거하고 알코올 성분을 제거하는 단계; 및 상기 발효 추출물을 여과기로 여과하여 정제하는 단계;를 더 포함함을 특징으로 한다.In addition, the secondary herbal fermentation extract manufacturing step, the step of mixing each of the primary fermentation extract into a fermenter; Removing the microorganism from the fermented extract of the second fermentation and removing the alcohol component; And purifying the fermented extract by filtration with a filter.
이때, 상기 정제 단계는, 멸균 처리한 발효 추출액을 4℃ 냉장고에 3일 이상 방치하여 중력의 작용으로 입자형태의 고형물이 침전시키는 단계; 상기 고형물로부터 맑은 상층액을 분리하기 위해 사이펀 현상을 이용하여 다른 용기에 상층액을 옮기고, 잔유물을 5μ여과기를 이용하여 고형 입자 제거 및 여분의 생약 추출물을 여과하여 분리액을 용기에 합하는 단계; 및 micro pore membrane filter를 이용하여 사멸한 미생물과 미세한 불순물을 제거하여 발효추출물을 정제하는 단계;를 포함함을 특징으로 한다.
At this time, the purification step, the step of leaving the sterilized fermentation extract in a 4 ℃ refrigerator for more than 3 days to precipitate a solid in the form of particles by the action of gravity; Transferring the supernatant to another vessel by using a siphon phenomenon to separate the clear supernatant from the solid, and removing the solid particles using a 5 μ filter on the residue and filtering the excess herbal extract to combine the separation solution into the vessel; And purifying the fermentation extract by removing dead microorganisms and fine impurities using a micro pore membrane filter.
본 발명에 따른 발모제의 조성물 및 이의 제조 방법은 다음과 같은 효과를 가진다.The composition of the hair regrowth agent and the manufacturing method thereof according to the present invention has the following effects.
첫째, 본 발명은 남성호르몬의 노폐물인 DHT 작용을 억제하여 발모를 촉진한다.First, the present invention promotes hair growth by inhibiting DHT action, a waste product of male hormones.
둘째, 본 발명은 두피의 과민성 반응을 억제하여 발모를 촉진한다.Secondly, the present invention promotes hair growth by inhibiting hypersensitivity reactions of the scalp.
셋째, 두피의 지질 과잉 방출을 억제하여 지용성 두피를 개선하여 발모를 촉진한다.Third, it inhibits excessive release of lipids of the scalp to improve fat-soluble scalp and promote hair growth.
넷째, 두피 조직의 이완 및 모세혈관의 혈류 양을 개선하여 모근 활성을 촉진하여 발모를 촉진한다.
Fourth, to relax the scalp tissue and improve the amount of blood flow in the capillaries to promote hair root activity to promote hair growth.
도 1은 본 발명의 일실시예에 따른 임상 결과를 나타내는 도면.1 is a view showing the clinical results according to an embodiment of the present invention.
이하 첨부된 도면과 함께 본 발명의 바람직한 실시 예를 살펴보면 다음과 같으며, 본 발명을 설명함에 있어서 관련된 공지기술 또는 구성에 대한 구체적인 설명이 본 발명의 요지를 불필요하게 흐릴 수 있다고 판단되는 경우에는 그 상세한 설명은 생략할 것이며, 후술되는 용어들은 본 발명에서의 기능을 고려하여 정의된 용어들로서 이는 사용자, 운용자의 의도 또는 관례 등에 따라 달라질 수 있으므로, 그 정의는 본 발명인 발모제의 조성물 및 이의 제조방법을 설명하는 본 명세서 전반에 걸친 내용을 토대로 내려져야 할 것이다.Looking at a preferred embodiment of the present invention together with the accompanying drawings as follows, when it is determined that the detailed description of the known art or configuration related to the present invention may unnecessarily obscure the subject matter of the present invention The detailed description will be omitted, and the following terms are terms defined in consideration of functions in the present invention and may vary according to the intention or custom of the user or operator, and the definitions refer to the composition of the present invention and the preparation method thereof. It should be made based on the contents throughout the specification to be described.
이하, 본 발명의 바람직한 실시예에 따른 발모제의 조성물에 대한 성분과 특징을 설명하면 다음과 같다.Hereinafter, the components and features of the composition of the hair regrowth agent according to the preferred embodiment of the present invention will be described.
본 발명에 따라 발모제의 조성물은 톳, 숙지황, 고삼, 마늘, 구기자, 검은콩 등의 6종류의 조성물을 원료로 하여 구성된다. 또한, 스프레이형 두피 도포형 발모제 제형에는 상기 6종류의 조성물에 지용성과 수용성 추출물 및 두피 지질 성분과의 친화성을 높여 두피 흡수를 완전하게 하고자 천연 유화제인 올리브 리퀴드를 사용하고, 모근 세포대사 촉진 물로 비타민 C, 리보플라빈, 피리독신 등의 비타민을 첨가하고, 두피 보습제로 알로에 추출물을 사용한다.According to the present invention, the composition of the hair regrowth is composed of six kinds of compositions such as 톳, sukji sulfur, red ginseng, garlic, wolfberry, and black beans as raw materials. In addition, the spray-type scalp-coating hair regrowth formulations use olive liquid, a natural emulsifier, to promote hair root cell metabolism, in order to complete the absorption of the scalp by increasing the affinity of the fat-soluble, water-soluble extract and scalp lipid components in the six types of compositions. Add vitamins such as vitamin C, riboflavin and pyridoxine, and use aloe extract as a scalp moisturizer.
본 발명에서는 기존 발모제의 화학물질, 호르몬제의 사용으로 발생하는 부작용을 방지하기 위해, 생약으로부터 추출한 천연 성분을 이용하므로 두피에 무해하다는 장점이 있다.In the present invention, in order to prevent side effects caused by the use of chemicals and hormones of the existing hair regrowth agent, there is an advantage that it is harmless to the scalp because it uses a natural ingredient extracted from the herbal medicine.
한편, fucoidan, fucosterol, fucoxanthine, gamma amino butyric acid 등을 함유한 갈조류는 다시마, 톳의 순으로 높지만, 다시마에는 불용성인 알긴산의 함량이 높기 때문에, 본 발명에서는 다시마 보다는 점액 다당체의 알긴산 성분이 극히 적은 톳을 주성분으로 사용한다.On the other hand, brown algae containing fucoidan, fucosterol, fucoxanthine, gamma amino butyric acid are higher in the order of kelp and ,, but the alginate component of the mucopolysaccharide is less than that of kelp in the present invention, because the content of alginic acid is insoluble in kelp. Is used as the main ingredient.
상기한 알긴산은 경구 투여에는 독성이 없지만 혈관 투여는 부작용을 초래하며, 거대 분자량의 점조성 다당체로서 두피 도포용으로는 부적합하여 알긴산을 제거하여야 한다. 알긴산 제거를 위한 기존 방법에는 황산을 첨가하여 침전물을 분리하는 방법을 이용하지만, 두피에 부작용을 발생하므로 톳의 발효추출물에서 알긴산 제거는 -20℃이하에서 동결 침전시켜 분리하는 법을 이용한다.Alginic acid is not toxic for oral administration, but vascular administration causes side effects, and is a macromolecular polysaccharide of high molecular weight, which is not suitable for scalp application and should be removed. Existing methods for removing alginic acid use a method of separating sediment by adding sulfuric acid, but since side effects occur in the scalp, the removal of alginic acid from fermented extract of 톳 uses a method of freezing precipitation below -20 ° C.
또한, 추출하는 기존 방법으로 유기용매 추출법, 산 가수분해와 가열추출법 등을 사용하는 화학공정법을 이용한 추출물에는 미량의 유해한 화학 잔존물이 존재하여 피부에 자극 및 손상, 기능성 물질의 변화와 감소를 초래할 수 있어, 본 발명에서는 기능성 물질의 손실과 변화를 방지할 수 있는 미생물 발효공법으로 천연 발효 추출법을 이용한다.In addition, traces of harmful chemical residues are present in the extracts using organic solvent extraction, acid hydrolysis and heat extraction, which may cause irritation and damage to the skin and change and reduction of functional substances. In the present invention, the natural fermentation extraction method is used as a microbial fermentation method that can prevent the loss and change of functional substances.
이때, 발효에 사용한 균주는 'Saccharomyces.spp'를 사용하며, 균주의 영양원으로 5?10% 분량으로 가당하여 완전 발효시킴으로써 생약 추출물 성분이 안정화되고 발효 미생물이 대사과정에서 생성하는 효소작용으로 저분자 물질로 전환됨으로써 두피 흡수력을 증가시켜 유효 기능성을 증대시킨다.At this time, the strain used for fermentation uses 'Saccharomyces.spp', and the fermented microorganism extract component is stabilized by fermentation with 5 ~ 10% amount as a nutrient source of the strain and the fermentation microorganism produces low-molecular substances. Conversion to the scalp increases the effective functionality.
또한, 발효공정에서 발효조는 발효에 유해한 불필요한 미생물을 제거하기 위해 70% alcohol을 분무하여 소독한다. 소독이 완료된 후 가열 추출물과 각 원료의 추출 박을 함께 투입하여 상온의 25?37℃ 온도에서 완전한 발효 추출과정을 도입하여 적은 원료의 양으로 최대의 완전한 성분을 추출할 수 있는 방법을 이용한다.In addition, in the fermentation process, the fermenter is sterilized by spraying 70% alcohol to remove unnecessary microorganisms harmful to fermentation. After the disinfection is completed, the heated extract and the extraction foil of each raw material are added together to introduce a complete fermentation extraction process at a temperature of 25 ~ 37 ℃ at room temperature to extract the maximum complete components in a small amount of raw materials.
한편, 발효공정은 각 원료별로 3개월간의 1차 발효 후, 톳을 제외한 생약 발효물을 대형 발효조에 혼합하여 생약 성분의 균질화를 이루고자 3개월 이상 2차 발효법을 이용한다.Meanwhile, the fermentation process uses a secondary fermentation method for at least three months to achieve homogenization of the herbal components by mixing the fermented medicinal products except for 톳 in a large fermenter after the first fermentation for each raw material for three months.
이때, 발효공정에서 생성된 알코올성분 제거와 대량 증식한 미생물을 사멸시키기 위한 방법으로 121℃ 15파운드 압력에서 15분간 고압멸균법을 이용한다. 또한, 사멸한 미생물과 발효 추출물의 미세 입자를 제거하여 정제하는 과정으로 음압의 'micro pore membrane filter' 법을 이용한다.At this time, a high-pressure sterilization method is used for 15 minutes at 121 ℃ 15 pound pressure as a method for removing the alcohol component produced in the fermentation process and killing the microorganisms that have grown in mass. In addition, by removing the microorganisms and the fine particles of the fermented extracts are killed using a negative pressure 'micro pore membrane filter' method.
이와 같이 2차 생약 발효 추출물이 제조되면, 스프레이형 두피 도포형 발모제의 제형을 위해 올리브 리퀴드를 천연 유화제로 사용한다. 즉, 제형에 첨가되는 올리브 리퀴드는 발효추출물의 지용성 성분과 수용성 성분을 균질화 시키는 천연 유화제로 사용되며, 또한 지용성 두피의 지질 성분을 유화시켜 유효 성분의 투피 침투력을 증가시킨다.When the second herbal fermented extract is prepared as described above, olive liquid is used as a natural emulsifier for the formulation of spray-type scalp-coated hair repellent. In other words, the olive liquid added to the formulation is used as a natural emulsifier to homogenize the fat-soluble component and the water-soluble component of the fermented extract, and also emulsifies the lipid component of the fat-soluble scalp to increase the permeability of the active ingredient.
아울러, 모근 세포대사 촉진 물로 비타민 C, 리보플라빈, 피리독신 등의 비타민을 첨가하고, 두피 보습제로 알로에 추출물을 사용함으로써 두피 도포용 천연 발효 발모제를 제조한다.In addition, vitamin C, riboflavin, pyridoxine, and the like are added as hair root cell metabolism promoting water, and aloe extract is used as a scalp moisturizer to prepare a natural fermenting hair growth agent for applying the scalp.
이하, 상술한 본 발명에 따른 발모제의 각 성분 및 각 제조 단계를 보다 상세히 설명한다.
Hereinafter, each component and each manufacturing step of the hair regrowth agent according to the present invention described above will be described in more detail.
<톳 발효 추출물 제조><톳 fermented extract preparation>
항혈액 응고작용이 우수한 'fucoidan'을 함유한 갈조류는 다시마, 톳의 순으로 기능이 높지만, 다시마에는 분자량이 20,000?240,000의 불용성 및 점조성 물질인 알긴산의 함량이 높다. 알긴산은 유효 성분의 두피 침투를 방해하는 불필요한 물질로서, 이를 제거하기 위한 방법으로 일반적으로는 황산 침전법으로 침전한 후 정제하는데, 이는 강산성 화학약품을 사용하므로 피부 자극성이 발생하는 단점이 있다.Brown algae containing 'fucoidan', which has excellent anticoagulant function, have high function in order of kelp and ,, but kelp has a high content of alginic acid, an insoluble and viscous substance of 20,000-240,000. Alginic acid is an unnecessary substance that prevents the penetration of the active ingredient into the scalp. As a method for removing the alginate, it is generally precipitated by sulfuric acid precipitation and purified. This has a disadvantage in that skin irritation occurs due to the use of strongly acidic chemicals.
본 발명에서는 다시마에 비해 알긴산 함유량이 적은 톳을 원료로 사용하며, 톳에는 알긴산이 미량 존재하므로 냉동 침전 후 저온 여과법으로도 알긴산의 제거가 가능하다.In the present invention, it is used as a raw material having less alginic acid content than the kelp as a raw material, since there is a small amount of alginic acid in the algae, it is possible to remove alginic acid by low temperature filtration after freezing precipitation.
톳에는 Fucosterol, Fucoidan, Fucoxanthine, Gamma Amino Butyric Acid, 무기질(K, Ca, Mg, Na, Fe, Mn, Zn, Cu,), 비타민 C, beta-carotene, alpha-tocopherol, polyphenol 등의 성분이 포함되어 있으며, 각 성분의 작용은 다음과 같다.톳 contains ingredients such as Fucosterol, Fucoidan, Fucoxanthine, Gamma Amino Butyric Acid, minerals (K, Ca, Mg, Na, Fe, Mn, Zn, Cu,), vitamin C, beta-carotene, alpha-tocopherol, polyphenol The action of each component is as follows.
1) Fucosterol : 혈중 지질개선, 혈류량 개선, 항산화작용, cholesterol 및 혈압 상승 억제 작용.1) Fucosterol: improves blood lipids, improves blood flow, antioxidant activity, inhibits cholesterol and blood pressure rise.
2) Fucoidan : 항응고성 활성 작용인 항혈액응고작용, 항산화작용, 면역부활, 항종양, 항암, 항바이러스 등의 기능.2) Fucoidan: anticoagulant, anticoagulant, antioxidant, immune resilience, anti-tumor, anti-cancer, anti-viral function.
3) Fucoxanthine : 갈조류에 함유된 카로티노이드의 일종으로 지방 연소작용, 항산화작용, 항암활성작용.3) Fucoxanthine: A type of carotenoid contained in brown algae, fat burning, antioxidant and anticancer activity.
4) Gamma Amino Butyric Acid : 억제성 신경전달 물질의 작용, cholesterol 저하 작용, triglyceride 저하 작용.4) Gamma Amino Butyric Acid: Inhibitory neurotransmitter, cholesterol lowering, triglyceride lowering action.
5) 무기질 : 모근 세포의 세포대사에서 산염기 평형, 효소 활성화, 단백질합성의 촉매 작용.5) Minerals: Catalytic acid equilibrium, enzyme activation, and protein synthesis in cell metabolism of hair root cells.
6) 비타민 C : 항산화물질로, 교원섬유 생성작용, 모 유두 세포의 성장, 모간 생장 촉진 작용.6) Vitamin C: Antioxidant, collagen fiber production, dermal papilla cells growth, hair shaft growth promoting action.
또한, 톳에는 항응고성 활성 작용인 항혈액 응고작용, 항산화작용, 면역부활, 항종양, 항암, 항바이러스, 혈류량 개선, 신경전달 물질의 작용, cholesterol 저하 작용, triglyceride 저하 작용, 모근 세포의 세포대사에서 산염기 평형, 효소 활성화, 단백질합성의 촉매 작용교원섬유 생성작용, 모 유두 세포의 성장, 모간 생장 촉진 작용 등의 생리활성 기능이 있다.
In addition, anticoagulant activity, anticoagulant, antioxidant, immune resiliency, anti-tumor, anti-cancer, anti-viral, blood flow improvement, neurotransmitter, cholesterol lowering, triglyceride lowering, hair follicle cells In metabolism, there are physiological activities such as acid group equilibrium, enzyme activation, catalysis of protein synthesis, collagen fiber production, growth of dermal papilla cells, and hair growth promotion.
이하, 톳 발효 추출물 제조 방법을 상세히 설명한다.
Hereinafter, 톳 fermented extract manufacturing method will be described in detail.
1) 톳 발효 추출 공정1) fermentation extraction process
① 세척 및 분쇄 : 톳 40?60g을 물에 세정하여 염분을 제거하고, 1차 수분 건조 후 1?2mm 크기로 분쇄한다.① Washing and grinding: 톳 Wash 40 ~ 60g in water to remove salt, and after 1st water drying, grind to 1-2mm size.
② 살균 처리과정 : 분쇄한 톳 분말을 100℃ 물에서 10분간 가열 추출 및 살균 처리한 후 상온으로 냉각한다.② Sterilization process: After grinding and extracting sterilized powder for 10 minutes in 100 ℃ water, and cooled to room temperature.
③ 발효공정 : 발효조는 70% alcohol을 분무하여 소독하고, 발효조에 물 1kg, 살균 처리한 톳과 추출물을 함께 투입하고, 5?10% 분량으로 가당한 후, Saccharomyces.spp 균주를 접종한다.③ Fermentation process: The fermenter is sprayed with 70% alcohol and disinfected. 1kg of water and sterilized sesame extract are added together, fermented with 5-10% of the fermenter, and then inoculated with Saccharomyces.spp strain.
④ 발효 온도 및 기간 : 35℃에서 6개월 이상 발효 추출한다.④ Fermentation temperature and duration: Extract fermentation for more than 6 months at 35 ℃.
⑤ 멸균처리 및 알코올 성분 제거 과정 ; 발효 추출액의 상층액을 분리한 후, 그 액을 121℃ 15파운드 압력에서 15분간 고압멸균 처리하여 미생물을 사멸시키고, 발효과정에서 생성되어 발효액에 존재하는 알코올 성분을 휘발시킨다.
⑤ sterilization and alcohol removal process; After the supernatant of the fermentation extract is separated, the solution is autoclaved at 121 ° C. 15 pounds pressure for 15 minutes to kill microorganisms, and volatilizes the alcohol component produced during the fermentation.
2) 톳 추출물의 알긴산 분리 공정2) Alginic Acid Separation Process
① 멸균한 톳 추출물을 -20℃ 이하의 냉동고에서 완전한 침전을 위해 3일 이상 냉동 처리한다.① Sterilize 톳 extracts in freezer at -20 ℃ or lower for 3 days or more to ensure complete precipitation.
② 냉동 처리한 톳 추출물을 4℃에서 해동한다.② thaw frozen extract 톳 at 4 ℃.
③ 해동된 추출물에서 침전된 알긴산과 맑은 상층액을 분리하기 위해 사이펀 현상을 이용하여 다른 용기에 상층액을 옮기고, 잔유물을 25μ여과기를 이용하여 알긴산의 제거 및 여분의 톳 추출물을 여과하여 용기에 합한다.
③ To separate alginic acid precipitated from the thawed extract and clear supernatant, transfer the supernatant to another vessel using siphon phenomenon, remove the alginic acid using a 25μ filter, and filter out the remaining extract. .
3) 정제과정3) Purification Process
'micro pore membrane filter'의 효율성을 높이기 위해 1차적으로 5μ여과기로 여과 분리하고 최종 정제 과정으로 2차 여과공정을 도입한다.In order to increase the efficiency of the 'micro pore membrane filter', it is first separated by filtration with a 5μ filter and a second filtration process is introduced as a final purification process.
① 1차 정제과정 : 알긴산을 분리한 톳 발효 추출액을 4℃ 냉장고에 3일 이상 방치하면 중력의 작용으로 입자형태의 고형물이 침전된다. 고형물로부터 맑은 상층액을 분리하기 위해 사이펀 현상을 이용하여 다른 용기에 상층액을 옮기고, 잔유물을 5μ여과기를 이용하여 고형 입자 제거 및 여분의 생약 추출물을 여과하여 분리액을 용기에 합한다.① 1st refining process: 알 Fermented extract separated from alginic acid is left in 4 ℃ refrigerator for more than 3 days to precipitate solids in the form of particles by the action of gravity. In order to separate the clear supernatant from the solid, the supernatant is transferred to another vessel using a siphon phenomenon, and the residue is combined with the vessel by removing the solid particles using a 5 μ filter and filtering the extra herbal extract.
② 2차 정제과정 : 'micro pore membrane filter'를 이용하여 사멸한 미생물과 미세한 불순물을 제거하여 발효추출물을 정제한다.
② Secondary purification process: Purify fermented extract by removing dead microorganisms and fine impurities using 'micro pore membrane filter'.
이와 같이, 톳 발효 추출물 제조 방법을 설명하였으며, 다음으로, 숙지황, 고삼, 마늘, 구기자, 검은콩 등의 생약 성분에 대한 발효 추출물 제조 방법을 설명한다.
As described above, 톳 fermented extract manufacturing method has been described, and then, the fermented extract manufacturing method for herbal ingredients such as sukji sulfur, red ginseng, garlic, wolfberry, black beans and the like.
<1차 생약 발효 추출물 제조><Preparation of primary herbal fermented extract>
1. 숙지황 발효 추출물 제조1. Manufacture of Sookjihwang Fermented Extract
숙지황에는 catapol, rehmannin, aucubin, rehmannioside(A, B, C, D), leonuride, monomeltittoside, dihydrocatalpol, amino acid, 기타 미량원소 등을 함유하고 있다.Sukjiwang contains catapol, rehmannin, aucubin, rehmannioside (A, B, C, D), leonuride, monomeltittoside, dihydrocatalpol, amino acid, and other trace elements.
동의보감에 숙지황은 성질이 따뜻하며 단맛과 쓴맛을 갖는다고 기록되어 있다. 숙지황은 혈허를 보충하며 모발을 검게 하고, 골수를 메우며 근육을 건강하게 한다. 또 뼈를 튼튼하게 하며 허약한 것을 보충하고 혈맥을 통하게 하며 기력을 증강시키고 귀와 눈을 건강하게 한다고 했다. 또한, 모발의 원료는 혈액이며 두피로의 혈액순환이 원활하면 모발이 윤기 있고 굵지만 혈액 순환이 안되면 모발이 거칠어지고 가늘어지면서 탈모가 나타난다고 기록되어 있다.In agreement, Sooji Hwang is said to be warm and have a sweet and bitter taste. Sukjiwang replenishes the blood and blackens the hair, fills the bone marrow and makes the muscles healthy. He also said that it strengthens bones, replenishes weaknesses, makes blood flow through, improves energy, and keeps ears and eyes healthy. In addition, it is recorded that the raw material of the hair is blood, and if the blood circulation to the scalp is smooth, the hair is glossy and thick, but if blood circulation is not possible, the hair becomes rough and thin and hair loss appears.
피가 부족하면 모발이 가늘어지고 탈모가 나타나며 얼굴에 화색이 없어 창백해지고 어지럽다. 또 눈이 피로하고 손발이 저리면서 손발톱이 창백해진다. 치료를 통한 심혈관 및 신경계통 질환 치료제로 사용되는 숙지황의 손상된 척수축삭에 대한 성장촉진효과가 검증되었다.Lack of blood results in thinning hair, hair loss, and paleness and dizziness due to lack of color on the face. The eyes become tired and the hands and feet go away, and the nails become pale. The growth-promoting effect of Sukjiwang used for the treatment of cardiovascular and neurological diseases through the treatment of damaged spinal cord axon was verified.
또한, 숙지황은 total cholesterol과 triglyceride 저하 작용, 항노화작용과 관련하여 glutathione peroxidase 활성 상승, 혈청 과산화지질함량을 감소, super oxide dismutase 활성 증가 등의 항산화 효과 등의 생리활성 작용을 한다.
In addition, succinate sulfur has physiological activities such as lowering total cholesterol and triglyceride, antioxidative effects such as increasing glutathione peroxidase activity, decreasing serum peroxide lipid content, and increasing super oxide dismutase activity.
- 숙지황 1차 발효 추출물 제조 공정-Sukjihwang 1st fermentation extract manufacturing process
① 세척 : 숙지황을 30?60g 을 물에 세정하여 불순물을 제거한다. ① Washing: Wash 30 ~ 60g of Sukji sulfur with water to remove impurities.
② 살균 처리과정 : 세정한 숙지황을 100℃ 물에서 10분간 가열 추출 및 살균 처리한 후 상온으로 냉각한다.② Sterilization process: After heating and extracting sterilized sulfuric acid in 100 ℃ water for 10 minutes, it is cooled to room temperature.
③ 발효공정 : 발효조는 70% alcohol을 분무하여 소독하고, 발효조에 물 1 kg, 살균 처리한 숙지황과 추출물을 함께 투입하고, 5?10% 분량으로 가당한 후, Saccharomyces.spp 균주를 접종한다.③ Fermentation process: The fermenter is sprayed with 70% alcohol and disinfected. 1 kg of water, sterilized sujihwang and extract are added together, fermented with 5-10% of the fermenter, and then inoculated with Saccharomyces.spp strain.
④ 1차 발효 온도 및 기간 : 35℃에서 3개월 발효 추출한다.
④ 1st fermentation temperature and period: Extract fermentation 3 months at 35 ℃.
2. 고삼 1차 발효 추출물 제조2. Preparation of the First Fermented Extract of Ginseng
고삼은 alkaloid 화합물로서 matrine, matrin N-oxide, allomatrine, isomatrine, sophoranol, sophoranol N-oxide, sophoramine, N-methylcytisine, anagyrine, batifoline 등이 함유되어 있으며, 식물성 에스트로겐(phytoestrogen)성분으로서 daidzein, genistein, formonoetin 등의 isoflvones 화합물로 구성된다.Ginseng is an alkaloid compound that contains matrine, matrin N-oxide, allomatrine, isomatrine, sophoranol, sophoranol N-oxide, sophoramine, N-methylcytisine, anagyrine, batifoline, and phytoestrogen. It is composed of such isoflvones compounds.
또한, 고삼은 알러지성 과민반응에서 histamine, cytokine, β-hexosaminidase 등의 활성 억제 작용으로 탈모방지와 습진 등의 피부염, 피부 가려움증, 항균작용 등에 효과가 있다.
In addition, ginseng inhibits the activity of histamine, cytokine, and β-hexosaminidase in allergic hypersensitivity, and is effective in preventing hair loss, dermatitis such as eczema, skin itching, and antibacterial activity.
- 고삼 발효 추출물 제조 공정-Ginseng Fermented Extract Manufacturing Process
① 세척 : 고삼 30?60g를 물에 세정하여 불순물을 제거한다. ① Washing: Wash 30 ~ 60g of red ginseng in water to remove impurities.
② 살균 처리과정 : 세정한 고삼을 100℃ 물에서 10분간 가열 추출 및 살균 처리한 후 상온으로 냉각한다.② Sterilization process: The washed ginseng is extracted and sterilized by heating for 10 minutes in 100 ℃ water and cooled to room temperature.
③ 발효공정 : 발효조는 70% alcohol을 분무하여 소독하고, 발효조에 물 1 kg, 살균 처리한 고삼과 추출물을 함께 투입하고, 5?10% 분량으로 가당한 후, Saccharomyces.spp 균주를 접종한다.③ Fermentation process: The fermenter is sprayed with 70% alcohol and disinfected. 1 kg of water and sterilized gourdaceae extract are added to the fermenter together. After fermentation with 5 ~ 10%, inoculate Saccharomyces.spp strain.
④ 1차 발효 온도 및 기간 : 35℃에서 3개월 발효 추출한다.
④ 1st fermentation temperature and period: Extract fermentation 3 months at 35 ℃.
3. 마늘 1차 발효 추출물 제조3. Garlic primary fermentation extract manufacturing
마늘에는 alliin, allicin, ajoene, scordinin, fructooligosaccharide, allithiamine과 essential oil 성분으로는 citral, geraniol, linanol, α-β-phellandrene 등의 생리 활성 물질과 마늘 비타민 B1(알리티아민) 등이 함유되어 있다.Garlic contains alliin, allicin, ajoene, scordinin, fructooligosaccharide, allithiamine and essential oils such as citral, geraniol, linanol and α-β-phellandrene, as well as garlic vitamin B1 (altyamine).
마늘은 항균작용, 살충작용, 중성지방과 cholesterol 저하 작용, 혈전용해작용으로 모세혈관혈액 순환 개선작용, 지질과산화억제작용으로 혈관 내피세포보호, 항산화작용, 항암작용 등에 효과가 있어 혈액 중의 콜레스테롤의 일종인 혈중 지질을 감소시키는 작용을 한다. 이 때문에 동맥경화. 고혈압의 예방, 치료제로서 각광을 받는다. 또한 피부의 말초 혈관을 확장시켜 피의 순환을 원활하게 하는 생리활성 작용을 한다.
Garlic is an antibacterial, insecticidal, triglyceride and cholesterol lowering agent, thrombolytic action to improve capillary blood circulation, lipid peroxidation inhibitory effect on vascular endothelial cell protection, antioxidant activity, anti-cancer effect. It acts to reduce lipids in the blood. This is because of arteriosclerosis. Spotlighted as a preventive and therapeutic agent for hypertension In addition, by expanding the peripheral blood vessels of the skin has a physiological activity that facilitates blood circulation.
- 마늘 발효 추출물 제조 공정-Garlic Fermented Extract Manufacturing Process
① 세척 : 마늘 50?100g 을 물에 세정하여 불순물을 제거하고, 1?2mm 크기로 분쇄한다. ① Washing: Wash 50 ~ 100g of garlic with water to remove impurities and grind to 1-2mm size.
② 살균 처리과정 : 세정한 마늘을 100℃ 물에서 10분간 가열 추출 및 살균 처리한 후 상온으로 냉각한다.② Sterilization process: The washed garlic is extracted and sterilized by heating for 10 minutes in 100 ℃ water and cooled to room temperature.
③ 발효공정 : 발효조는 70% alcohol을 분무하여 소독하고, 발효조에 물 1 kg, 살균 처리한 마늘과 추출물을 함께 투입하고, 5?10% 분량으로 가당한 후, Saccharomyces.spp 균주를 접종한다.③ Fermentation process: The fermenter is sprayed with 70% alcohol and sterilized. 1 kg of water, sterilized garlic and extracts are added together, and fermented with 5-10% of the fermenter, and then inoculated with Saccharomyces.spp strain.
④ 1차 발효 온도 및 기간 : 35℃에서 3개월 발효 추출한다.
④ 1st fermentation temperature and period: Extract fermentation 3 months at 35 ℃.
4. 구기자 1차 발효 추출물 제조4. Preparation of Gojija Primary Fermentation Extract
구기자에는 betaine, rutin, diosgenin, physalien, zeaxanthin, uracil, β-sitosterol, palmitic acid , linolenic acid, cornin, morrnoniside, loganin, tanin, saponin, ascorbic acid, mineral, amino acid 등의 성분이 존재한다.Wolfberry contains betaine, rutin, diosgenin, physalien, zeaxanthin, uracil, β-sitosterol, palmitic acid, linolenic acid, cornin, morrnoniside, loganin, tanin, saponin, ascorbic acid, mineral, amino acid.
구기자는 세포 면역력 강화 작용으로 DHT함량을 감소시켜 탈모방지 및 발모효과, 노화방지, 해독작용, 세포복제기능강화, 모세혈관 강화, 항산화작용, 혈액 내 cholesterol 감소, 콜라겐 합성 등의 생리활성 작용이 있다.Gojija has a physiological activity such as anti-hair loss and hair growth effect, anti-aging, detoxification, cell replication function, capillary reinforcement, antioxidant activity, cholesterol reduction in blood, collagen synthesis by reducing DHT content by enhancing cellular immunity. .
한방에서는 강장제 또는 해열제로 쓰고 간기능 보호 작용이 뛰어나 부작용이 별로 없다. 또한, 시력을 좋게 하고 당뇨병 등의 성인병을 예방하며 폐와 신장의 기능을 좋게 하고, 들기름과 섞어 숙성해 두었다가 머리에 바르면 흰머리가 생기는 것을 막아 주는 효과가 있다.In oriental medicine, it is used as a tonic or antipyretic and has excellent liver function protection, so there are few side effects. In addition, it improves vision and prevents adult diseases such as diabetes, improves the function of lungs and kidneys, and mixes with perilla oil to mature and then applied to the hair to prevent the occurrence of gray hair.
아울러, 구기자에는 조혈작용, 콜레스테롤강하작용, 항지방간작용, 혈압강하, 혈당강하, 생장촉진, 항암작용 등의 성분인 베타인, 베아크산틴, 카로텐, 티아민, 비타민A, B1, B2, C 등이 함유되어 있다. 구기열매 구기자의 효능은 만성간염, 간경변증, 강장제, 해열제로 허리요통에 쓰인다. 구기자뿌리 껍질은 지골피(地骨皮)라 하여 한방에서 소갈, 오한 등의 해열제로 이용된다. 1800년 전 후한시대에 저술된 『신농본초경』에서는 상약(上藥), 즉 무독한 것으로 인삼과 구기 등을 들고 있다. 『본초경』에서는 오랫동안 복용하면 근골을 단단하게 하며 몸이 가벼워져서 늙지 않고 더위와 추위를 타지 않는다고 소개되어있다. 민간에서는 구기차 또는 구기주로 이용한다
In addition, gojija hematopoietic action, cholesterol lowering action, anti-fatty liver action, blood pressure drop, hypoglycemia, growth growth, anti-cancer and other components such as betaine, beaxanthin, carotene, thiamine, vitamin A, B1, B2, C, etc. It contains. The effects of goji berries goji are used for backache as chronic hepatitis, cirrhosis, tonic, antipyretic. Gugijaroot skin is called Jigolpi (地骨皮) is used as an antipyretic such as beef, chills, etc. in Chinese medicine. In the Xinong main menarche, written about 1800 years ago in the Hanhan period, it contains herbs, or ginseng, which are poisonous. 『Bonchogyeong』 has been introduced that it takes a long time to harden the musculature, lighten the body, so that it does not grow old and does not burn hot and cold. In civilian use, we use it as a goji or goji
- 구기자 발효 추출물 제조 공정-Gojija Fermented Extract Manufacturing Process
① 세척 : 구기자 30?60g 을 물에 세정하여 불순물을 제거한다. ① Washing: Wash 30 ~ 60g of wolfberry in water to remove impurities.
② 살균 처리과정 : 세정한 구기자를 100℃ 물에서 10분간 가열 추출 및 살균 처리한 후 상온으로 냉각한다.② Sterilization Process: After washing and sterilizing the heated wolfberry in 100 ℃ water for 10 minutes, cool it to room temperature.
③ 발효공정 : 발효조는 70% alcohol을 분무하여 소독하고, 발효조에 물 1 kg, 살균 처리한 구기자와 추출물을 함께 투입하고, 5?10% 분량으로 가당한 후, Saccharomyces.spp 균주를 접종한다.③ Fermentation process: The fermenter is sprayed with 70% alcohol and disinfected. 1 kg of water, sterilized goji and extract are added together, and fermented with 5-10% of the fermenter. Inoculate Saccharomyces.spp strain.
④ 1차 발효 온도 및 기간 : 35℃에서 3개월 발효 추출한다.
④ 1st fermentation temperature and period: Extract fermentation 3 months at 35 ℃.
5. 검은콩 1차 발효 추출물 제조5. Preparation of Black Bean Primary Fermentation Extract
검은콩에는 isoflavine, stachyrose, raffinose, sucrose, saponin, phytic acid, 필수아미노산, 불포화지방산의 linoleic acid, oleic acid, palmitic acid, 비타민 E, 단백질 등의 성분이 존재한다.Black soybean contains ingredients such as isoflavine, stachyrose, raffinose, sucrose, saponin, phytic acid, essential amino acid, unsaturated fatty acid linoleic acid, oleic acid, palmitic acid, vitamin E and protein.
또한, 검은콩에는 항산화효과, 식물성 estrogen 효과, cholesterol 저하, 만성질환 예방, 면역기능 강화, 지질산화반응 저하, 혈액순환을 촉진 등의 생리활성 작용이 있다.In addition, black beans have physiological activities such as antioxidant effect, vegetable estrogen effect, cholesterol lowering, chronic disease prevention, strengthening immune function, lowering lipid oxidation reaction, promoting blood circulation.
본초강목에는 검은콩의 효능에 대하여 "신장을 다스리고 부종을 없애며, 혈액 순환을 활발하게 하며 모든 약의 독을 풀어준다"고 기록되어 있다. 또한 모발 성장에 필수 성분인 시스테인(cysteine)이 함유되어 있어 탈모를 방지하는 데도 효과가 있다.
Herbal wood is written about the efficacy of black soybeans, "controls the kidneys, eliminates edema, activates blood circulation and releases the poison of all drugs." In addition, cysteine, an essential ingredient for hair growth, is also effective in preventing hair loss.
- 검은콩 발효 추출물 제조 공정-Black bean fermented extract manufacturing process
① 세척 및 분쇄 : 검은콩 50?80g를 물에 세정하여 불순물을 제거하고 수분을 건조한 후 1?2mm의 크기로 분쇄한다.① Washing and grinding: Wash 50 ~ 80g of black beans in water to remove impurities, dry moisture, and grind to 1 ~ 2mm.
② 살균 처리과정 : 세정한 검은콩을 100℃ 물에서 10분간 가열 추출 및 살균 처리한 후 상온으로 냉각한다.② sterilization process: The black soybeans are extracted and sterilized by heating for 10 minutes in 100 ℃ water and cooled to room temperature.
③ 발효공정 : 발효조는 70% alcohol을 분무하여 소독하고, 발효조에 물 1 kg, 살균 처리한 검은콩과 추출물을 함께 투입하고, 5?10% 분량으로 가당한 후, Saccharomyces.spp 균주를 접종한다.③ Fermentation process: The fermenter is sprayed with 70% alcohol and disinfected. 1 kg of water and sterilized black soybeans and extracts are added together, and fermented with 5-10% of the fermenter, and then inoculated with Saccharomyces.spp strain. .
④ 1차 발효 온도 및 기간 : 35℃에서 3개월 발효 추출한다.
④ 1st fermentation temperature and period: Extract fermentation 3 months at 35 ℃.
이상으로, 숙지황, 고삼, 마늘, 구기자, 검은콩 등의 생약 성분에 대한 1차 생약 발효 추출물 제조 방법을 설명하였다. 다음으로, 상기 1차 발효된 생약 추출물에 대한 2차 발효 제조 방법을 설명한다.
In the above, the method for preparing primary herbal fermented extracts for herbal ingredients such as sukji sulfur, red ginseng, garlic, wolfberry, and black beans has been described. Next, the secondary fermentation manufacturing method for the first fermented herbal extract.
<2차 생약 발효 추출물 제조><Second Herbal Fermented Extract Preparation>
상기와 같이 1차 발효된 생약 추출물의 성분 균질화를 이루고자 3개월 이상 2차 발효 공정을 추가로 처리한다.
In order to achieve the component homogenization of the first fermented herbal extract as described above, the secondary fermentation process is further processed.
1. 2차 발효 공정1. Second fermentation process
① 발효조는 70% alcohol을 분무하여 소독하고, 1차 발효물인 숙지황 발효 추출물, 고삼 발효 추출물, 마늘 발효 추출물, 구기자 발효 추출 물, 검은콩 발효 추출물 등의 5종을 대형 발효조에 투입하여 혼합한다.① Fermenter is sprayed with 70% alcohol and sterilized, and 5 kinds of primary fermentation products such as Sukjihwang fermentation extract, red ginseng fermentation extract, garlic fermentation extract, wolfberry fermentation extract and black soybean fermentation extract are mixed and mixed in a large fermenter.
② 2차 발효 온도 및 기간 : 30℃에서 3개월 이상 발효 추출한다.② Second fermentation temperature and period: Extract fermentation for more than 3 months at 30 ℃.
2. 멸균 및 알코올 제거 공정2. Sterilization and Alcohol Removal Process
① 멸균처리 및 알코올 성분 제거 과정 : 발효 추출액의 상층액을 분리한 후, 그 액을 121℃ 15파운드 압력에서 15분간 고압멸균 처리하여 미생물을 사멸시키고, 발효과정에서 생성되어 발효액에 존재하는 알코올 성분을 휘발시킨다.① Sterilization process and alcohol component removal process: After separating the supernatant of the fermentation extract, the solution is autoclaved at 121 ℃ 15 pounds pressure for 15 minutes to kill the microorganisms, alcohol components produced in the fermentation process and present in the fermentation broth Volatilize.
3. 정제과정3. Purification Process
' micro pore membrane filter'의 효율성을 높이기 위해 1차적으로 5μ여과기로 여과 분리하고 최종 정제 과정으로 2차 여과공정을 도입한다.In order to increase the efficiency of the 'micro pore membrane filter', the filter is first separated by a 5μ filter and a second filtration process is introduced as a final purification process.
① 1차 정제과정 : 멸균 처리한 발효 추출액을 4℃ 냉장고에 3일 이상 방치하여 중력의 작용으로 입자형태의 고형물이 침전한다. 고형물로부터 맑은 상층액을 분리하기 위해 사이펀 현상을 이용하여 다른 용기에 상층액을 옮기고, 잔유물을 5μ여과기를 이용하여 고형 입자 제거 및 여분의 생약 추출물을 여과하여 분리액을 용기에 합한다.① First purification process: Sterilized fermented extract is left in the 4 ℃ freezer for more than 3 days to precipitate solids in the form of particles. In order to separate the clear supernatant from the solid, the supernatant is transferred to another vessel using a siphon phenomenon, and the residue is combined with the vessel by removing the solid particles using a 5 μ filter and filtering the extra herbal extract.
② 2차 정제과정 : 'micro pore membrane filter'를 이용하여 사멸한 미생물과 미세한 불순물을 제거하여 발효추출물을 정제한다.
② Secondary purification process: Purify fermented extract by removing dead microorganisms and fine impurities using 'micro pore membrane filter'.
이상으로, 본 발명에 따른 톳 및 생약 5종 성분을 이용한 발효 발모제 제조 방법을 설명하였다. 상기 제조된 발효 발모제 조성물을 이용한 스프레이형 두피 도포형 발모제 제형을 위한 함량은 하기 <표 1>과 같으며, 이들 성분들의 함량은 제조자의 필요에 따라 변경이 가능하다.In the above, the method for producing a fermenting hair regrowth using the five components and the herbal medicine according to the present invention has been described. The content for the spray-type scalp-coated hair-repellent formulation using the prepared fermentation hair-repellent composition is as shown in Table 1, the content of these components can be changed according to the needs of the manufacturer.
<임상 실시예>Clinical Example
피검자 10명에게 본 발명에 따른 미생물 발효 공정으로 제조한 천연 발모제를 지급하여 매일 아침과 밤에 각 1회씩 탈모 부위에 분무한 후 가볍게 마사지 하도록 하였다.Ten subjects were given a natural hair regrowth prepared by the microbial fermentation process according to the present invention, and then sprayed to the hair loss site once every morning and night, and then massaged lightly.
피검자들의 만족도를 높이기 위하여 자가 평가 형태로 진행하였으며, 자가 평가는 이마의 중앙점을 기준하여 탈모부위를 선정하고, 1㎠의 넓이에서 생성된 모발의 개수를 관찰하여 모발의 증감을 조사하였다.In order to increase the satisfaction of the subjects, self-assessment was conducted. For the self-evaluation, the hair loss site was selected based on the center point of the forehead, and the number of hairs generated in the area of 1 cm 2 was examined to examine the increase and decrease of the hair.
톳, 숙지황, 고삼, 마늘, 구기자, 검은콩 등의 6종류의 생약 조성물을 원료로 하여, 발명에 따라 Saccharomyces.spp 미생물 발효공정으로 제조된 천연 발효 발모제를 탈모상태의 피검자 10명에게 위와 같은 방법으로 10주 동안 두피에 분무하게 하였으며, 그 결과에 대한 분석은 하기 <표 2>와 같다.As a raw material, six kinds of herbal compositions such as 톳, succinate, red ginseng, garlic, wolfberry and black soybean were used as raw materials. To spray for 10 weeks to the scalp, the analysis of the results are shown in Table 2 below.
기간apply
term
도 1은 상기 피검자 10명 중 7번째 피실험자(나이 33세, 남)에 대한 임상 전 및 임상 후의 사진이며, 본 발명에 따른 발모제 사용으로 발모에 상당한 효과가 나타남이 입증되었다.Figure 1 is a pre-clinical and post-clinical photograph of the seventh subject (age 33, male) out of 10 subjects, it was proved that a significant effect on the hair growth by using the hair regrowth agent according to the present invention.
이상에서 설명한 바와 같이, 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자가 본 발명의 기술적 사상을 벗어나지 않는 범위 내에서 여러 가지 치환, 변형 및 변경이 가능하므로 전술한 실시예 및 첨부된 도면에 한정되는 것은 아니다.
As described above, various substitutions, modifications, and changes can be made by those skilled in the art without departing from the technical spirit of the present invention, and thus, the embodiments and the accompanying drawings are limited. It doesn't happen.
Claims (9)
분쇄한 톳 분말을 살균 처리한 후, 35℃에서 6개월 이상 발효하여 추출한 톳 발효 추출물;
숙지황을 살균 처리한 후, 35℃에서 3개월간 발효하여 추출한 숙지황 발효 추출물;
고삼을 살균 처리한 후, 35℃에서 3개월간 발효하여 추출한 고삼 발효 추출물;
마늘을 살균 처리한 후, 35℃에서 3개월간 발효하여 추출한 마늘 발효 추출물;
구기자를 살균 처리한 후, 35℃에서 3개월간 발효하여 추출한 구기자 발효 추출물; 및
검은콩을 살균 처리한 후, 35℃에서 3개월간 발효하여 추출한 검은콩 발효 추출물;을 포함하며,
상기 숙지황 발효 추출물, 고삼 발효 추출물, 마늘 발효 추출물, 구기자 발효 추출물 및 검은콩 발효 추출물은 혼합하여 30℃에서 3개월 이상 2차 발효하는 것을 특징으로 하는 천연 발효 발모제 조성물.
In the composition of the hair regrowth agent,
톳 fermented extract extracted by fermentation at 35 ° C. for 6 months after sterilizing the pulverized powder;
Sukji sulfur fermented extract extracted by fermentation for three months after the sterilization of succinct;
After sterilizing the ginseng, fermented extract extracted by fermentation for 3 months at 35 ℃;
After the sterilization of garlic, garlic fermented extract extracted by fermentation for 3 months at 35 ℃;
After sterilization of the wolfberry, fermented extract extracting fermented for 3 months at 35 ℃; And
After sterilizing the black beans, fermented black bean extract extracted by fermentation for 3 months at 35 ℃; includes,
The fermented extract of Sukji sulfur, fermented ginseng extract, garlic fermented extract, goji berry fermented extract and black soybean fermented extract is a natural fermentation hair regrowth composition, characterized in that the secondary fermentation for at least 3 months at 30 ℃.
-20℃ 이하에서 동결 침전시켜 알긴산을 분리하는 것을 특징으로 하는 천연 발효 발모제 조성물.
According to claim 1, wherein the fermented extract is fermented,
Natural fermentation hair regrowth composition, characterized in that the alginate is separated by freeze precipitation at -20 ℃ or less.
물과 함께 각 살균 처리한 원료를 발효조에 투입하고, 5 내지 10중량%로 가당한 후, Saccharomyces.spp 균주를 접종하여 발효시키는 것을 특징으로 하는 천연 발효 발모제 조성물.
The method of claim 1, wherein the fermentation extract of each fermentation method,
A natural fermentation hair repellent composition, characterized in that the sterilized raw materials with water are added to a fermenter and added to 5 to 10% by weight, followed by inoculation of Saccharomyces.spp strains.
천연 유화제인 올리브 리퀴드, 모근 세포대사 촉진물로 비타민, 두피 보습제로 알로에 추출물을 더 포함함을 특징으로 하는 천연 발효 발모제 조성물.
2. The composition of claim 1,
Natural liquid emulsifier olive liquid, hair follicle cell metabolism promoter, vitamin, scalp moisturizer, characterized in that it further comprises aloe extract as a moisturizer.
분쇄한 톳 분말을 살균 처리한 후, 35℃에서 6개월 이상 발효하여 추출하는 톳 발효 추출물 제조 단계;
숙지황, 고삼, 마늘, 구기자 및 검은콩을 살균 처리한 후, 35℃에서 3개월간 발효하여 추출하는 1차 생약 발효 추출물 제조 단계; 및
상기 1차 발효된 숙지황 발효 추출물, 고삼 발효 추출물, 마늘 발효 추출물, 구기자 발효 추출물 및 검은콩 발효 추출물을 혼합하여 30℃에서 3개월 이상 2차 발효시키는 2차 생약 발효 추출물 제조 단계;를 포함함을 특징으로 하는 천연 발효 발모제 조성물의 제조 방법.
In the manufacturing method of the hair regrowth agent,
살균 fermented extract manufacturing step of sterilizing the pulverized 톳 powder, followed by extracting by fermentation for at least 6 months at 35 ℃;
After the sterilization treatment of Sookjihwang, gosam, garlic, wolfberry and black soybeans, the first herbal fermented extract manufacturing step of extracting by fermentation for 3 months at 35 ℃; And
It comprises a secondary fermentation extract manufacturing step of fermenting the first fermented Sookji sulfur fermentation extract, ginseng fermentation extract, garlic fermentation extract, goji berry fermentation extract and black soybean fermentation extract secondary fermentation for at least 3 months at 30 ℃; A method for producing a natural fermenting hair repellent composition characterized by the above.
상기 발효된 톳 추출물을 -20℃ 이하에서 동결 침전시켜 알긴산을 분리하는 단계;를 더 포함함을 특징으로 하는 천연 발효 발모제 조성물의 제조 방법.
The method of claim 5, wherein the fermented extract preparation step
The freeze precipitation of the fermented 톳 extract at -20 ° C or less to separate alginic acid; The method of producing a natural fermentation hair regrowth composition characterized in that it further comprises.
상기 각 원료를 세정하여 불순물을 제거하는 단계;
상기 세정된 원료를 살균한 후 상온에서 냉각하는 단계; 및
상기 살균 처리된 원료를 물과 함께 발효조에 투입하고, 5 내지 10중량%로 가당한 후, Saccharomyces.spp 균주를 접종하여 발효시키는 단계;를 포함함을 특징으로 하는 천연 발효 발모제 조성물의 제조 방법.
According to claim 5, The primary herbal fermentation extract manufacturing step,
Washing each raw material to remove impurities;
Sterilizing the washed raw materials and then cooling them at room temperature; And
Injecting the sterilized raw material into the fermenter together with water, and added to 5 to 10% by weight, inoculating the Saccharomyces.spp strain and fermentation; natural fermentation hair regrowth composition comprising a.
상기 각 1차 발효 추출물을 발효조에 투입하여 혼합하는 단계;
상기 2차 발효된 발효 추출물로부터 미생물을 제거하고 알코올 성분을 제거하는 단계; 및
상기 발효 추출물을 여과기로 여과하여 정제하는 단계;를 더 포함함을 특징으로 하는 천연 발효 발모제 조성물의 제조 방법.
According to claim 5, The secondary herbal fermentation extract manufacturing step,
Adding each of the primary fermentation extracts to a fermenter and mixing them;
Removing the microorganism from the fermented extract of the second fermentation and removing the alcohol component; And
Purifying the fermented extract by filtration with a filter; Method of producing a natural fermentation hair regrowth composition characterized in that it further comprises.
멸균 처리한 발효 추출액을 4℃ 냉장고에 3일 이상 방치하여 중력의 작용으로 입자형태의 고형물이 침전시키는 단계;
상기 고형물로부터 맑은 상층액을 분리하기 위해 사이펀 현상을 이용하여 다른 용기에 상층액을 옮기고, 잔유물을 5μ여과기를 이용하여 고형 입자 제거 및 여분의 생약 추출물을 여과하여 분리액을 용기에 합하는 단계; 및
micro pore membrane filter를 이용하여 사멸한 미생물과 미세한 불순물을 제거하여 발효추출물을 정제하는 단계;를 포함함을 특징으로 하는 천연 발효 발모제 조성물의 제조 방법.
The method of claim 8, wherein the purification step,
Leaving the sterilized fermentation extract in a 4 ° C. refrigerator for at least 3 days to precipitate solids in the form of particles by the action of gravity;
Transferring the supernatant to another vessel by using a siphon phenomenon to separate the clear supernatant from the solid, and removing the solid particles using a 5 μ filter on the residue and filtering the excess herbal extract to combine the separation solution into the vessel; And
Purifying the fermentation extract by removing the dead microorganisms and fine impurities using a micro pore membrane filter; Method of producing a natural fermentation hair regrowth composition comprising a.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110023819A KR101273518B1 (en) | 2011-03-17 | 2011-03-17 | Natural fermentation hair restorer and the manufacturing method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110023819A KR101273518B1 (en) | 2011-03-17 | 2011-03-17 | Natural fermentation hair restorer and the manufacturing method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20120106016A true KR20120106016A (en) | 2012-09-26 |
KR101273518B1 KR101273518B1 (en) | 2013-06-17 |
Family
ID=47112790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020110023819A Expired - Fee Related KR101273518B1 (en) | 2011-03-17 | 2011-03-17 | Natural fermentation hair restorer and the manufacturing method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101273518B1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200019097A (en) | 2018-08-13 | 2020-02-21 | 토탈바이오 주식회사 | Hair loss preventers and Hair growth |
KR102399220B1 (en) * | 2020-10-20 | 2022-05-19 | 주경준 | Manufacturing method of composition for scalp protection and hair growth acceleration |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100484236B1 (en) | 1997-08-27 | 2005-09-08 | 주식회사 엘지생활건강 | Hair Growth Promoting Composition |
KR20090022224A (en) * | 2007-08-30 | 2009-03-04 | 주식회사 코씨드바이오팜 | Cosmetic composition to promote scalp protection and hair growth |
KR100930839B1 (en) | 2007-11-16 | 2009-12-10 | 주혜경 | Herbal Shampoo Composition for Preventing Hair Loss and Hair Regrowth and Manufacturing Method Thereof |
KR20090092899A (en) * | 2008-02-28 | 2009-09-02 | 이병수 | Hair Growth Component Hastening Antimicrobial of Scalp and Growth of Hair Using Seaweed |
-
2011
- 2011-03-17 KR KR1020110023819A patent/KR101273518B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
KR101273518B1 (en) | 2013-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101373636B1 (en) | Composition for improving condition of skin and scalp containing fermented extracts of herb mixture | |
KR101550179B1 (en) | a composite for preventing depilation and growing hair | |
CN103340817B (en) | Radix puerariae whitening facial mask | |
KR101275971B1 (en) | Composition for antioxidation effect comprising sparassis crispa extract | |
KR101744103B1 (en) | Composition for preventing hair loss and promoting hair growth and mathod for preparing the same | |
KR101054378B1 (en) | Herbal soap composition and its manufacturing method | |
KR101374277B1 (en) | Composition for promoting hair growth containing fermented extracts of herb mixture | |
CN106860680A (en) | Golden flower ginseng pressed candies and preparation method thereof | |
KR101752232B1 (en) | Manufacturing Method of Composition for Hair growth promotion and Hair loss prevention | |
KR20110075626A (en) | Hair Regrowth Composition Using Natural Fermented Extract as Active Ingredient | |
KR101085948B1 (en) | Hair growth promoting composition and preparation method thereof | |
CN103041042B (en) | Tibetan medicine composition and application of composition in anti-off hair products | |
KR101273518B1 (en) | Natural fermentation hair restorer and the manufacturing method thereof | |
KR102082676B1 (en) | Composition for hair care | |
CN107319534A (en) | A kind of health food of antifatigue and beauty treatment and preparation method thereof | |
KR102265007B1 (en) | Composition for washing hair to prevent hair losing and to promote hair growth and manufacturing method for the same | |
KR102374056B1 (en) | Natural mixture for improving health and functional cosmetic and shampoo agent including the same for preventing hair loss | |
KR20090049390A (en) | A composition for preventing hair loss and hair growth and a method of manufacturing the same | |
CN109646359B (en) | Rose-agaric mud membrane paste with effects of cleaning, purifying, maintaining beauty and keeping young and preparation method thereof | |
CN107028182A (en) | A kind of anti-apolexis composition and preparation method | |
CN111067839A (en) | Conditioning repairing agent and preparation method thereof | |
CN102860507B (en) | Novel grape seed extract and preparation method thereof | |
CN108635618B (en) | Preparation method of medical adhesive with healing promoting and repairing functions | |
RU2639255C2 (en) | Method for producing cosmetic masks | |
CN112546087A (en) | A pharmaceutical composition for caring skin and oral cavity, and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20110317 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20130104 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20130531 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20130604 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20130605 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20160525 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20160525 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20170522 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20170522 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20180514 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20180514 Start annual number: 6 End annual number: 6 |
|
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20200315 |